- 冲击高端领域 捷尼赛思正式进入中国市场 车质网
- METHYLENEBIS ACRYLAMIDE, 2% SO
- Echelon_价格厂家供应商_默瑞(上海)生物科技有限公司 ...
- Synaptic Systems代理,Synaptic Systems授权代理商,Synaptic...
- Echelon 是脂质研究和脂质与蛋白质相互作用研究领域的领路者仪器资料...
- allelebiotech【allele biotech】【中国试剂网】 allelebiotech...
- 人纤维肉瘤细胞
- 供应DMOG (dimethyloxalylglycine)_价格厂家供应商_北京 ...
- echelon公司报价 echelon|产品详情|
- 小鼠三磷酸磷脂酰肌醇(PIP3)elisa检测试剂盒
- Echelon Biosciences Incorporated 上等代理|产品详情|上海蚂蚁淘...
- 日本Fujirebio公司将提供价格低廉的AIDS抗体试验《国外医学...
BrP-LPA, aka LPA bromophosphonate, acts as both an Autotaxin inhibitor (94% inhibition at 10 μM) and pan LPA receptor antagonist (LPA1: 1.5 μM, LPA2: 1.4 μM, LPA3: 1.2 μM, LPA4: 0.27 μM). BrP-LPA inhibits the invasiveness of NIH3T3 ras ATX cells by 40% and decreases chemotaxis by 23%. BrP-LPA reduces the size of breast (MDA-MB-231), colon (HCT-116) and melanoma (B16F10) tumors in mouse models. It also attenuates collagen-induced arthritis PPARγ is not activated by BrP-LPA.
Publications
1) Jiang, G., Y. Xu, et al. (2007). “Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA.” ChemMedChem 2(5): 679-90.2) Zhang, H., X. Xu, et al. (2009). “Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo.” Cancer Res 69: 54413) Schleicher, S. M., D. K. Thotala, et al. (2011). “Autotaxin and LPA Receptors Represent Potential Molecular Targets for the Radiosensitization of Murine Glioma through Effects on Tumor Vasculature.” PLoS ONE 6(7): e22182.4) Nikitopoulou, I., E. Kaffe, et al. (2013). “A Metabolically-Stabilized Phosphonate Analog of Lysophosphatidic Acid Attenuates Collagen-Induced Arthritis.” PLoS ONE 8(7): e70941
| Categories | Biochemical Reagents |
|---|---|
| Filter | Autotaxin, Inhibitor, Lysophosphatidic Acid |
| CAS Number | 944265-88-7 |
| Molecular Formula | C20H39BrNaO6P |
| Molecular Weight (g/mol) | 509.4 |
| Purity | 95% |
| Storage | -20 °C or below |


